BT8009
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BT8009, covering 2025-11-14 to 2025-11-14. Get the full timeline:
Most recent: Clinical Trial Update: Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies [Phase 1, Phase 2]